drugset / Trial / NCT02208284
A Single Oral Dose Study Of PF-06427878 In Healthy Adult Subjects
RandomizedCrossoverTriple-blindBasic science
Summary
PF-06427878 is a new compound proposed for the treatment of hyperlipidemia. The primary purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of single oral doses of PF-06427878 in healthy adult subjects.
Timeline
- Start
- 2014-08
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06427878 | Small molecule | — | Oral |
Indications
No indication recorded.